Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on May 07, 2019 1:28pm
100 Views
Post# 29720572

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Irwin does have a US play

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Irwin does have a US play
Alloparc wrote: I'll start by saying, I'm not speculating this is what is happening with the Schottenstein's... BUT:

Simon's previous response to a hostile event; aka Hain Celestial and "activist" investor Carl Icahn, when Ichan was taking a foot hold in Hain, Simon chose to reach an agreement & give him the seats on the board as Icahn requested instead of fighting him. 

“I had every banker call me, every lawyer, ‘You got to fight with him. You’ve got to get a poison-pill. You can’t give him board seats,’” Simon recalled. “You know what? Go run the company. How many companies go out there and fight with Carl and spend … millions in shareholder money?”

Instead of fighting him and spending shareholder money, he brought Icahn in.

Did the same thing again when another activist fund took a 9.9% stake in Hain years later, this time with 6 board seats.

It wouldn't surprise me his Simon is trying to bring the Schottenstein's into the fold, but I just don't logistically see it through the debentures, at least at this point.



jayjay2020 wrote:
INVSTIGAT0R wrote:
The whole article is just bashing Aphria and coming up with reasons why GGB would not get involved with us lol. Basically just said our brands, international operations and Canadian operations are all of marginal value.
All I am saying is I think the Schottensteins are pulling some strings at APHA. The $300M debenture coming up as soon as the GGB offer is expired just makes me think they are all connected. GGB wanted to own APHA.  This is an indirect way for GGB through Schottensteins to own  part of it in the future. I am ok with it if that is the case because they did not dilute shares and if Schottenstein's are commited to APHA I welcome them aboard.
 


Interesting point Alloparc.  Thanks for sharing

Bullboard Posts